Annual Operating Profit:
$97.57M+$10.25M(+11.74%)Summary
- As of today, PCRX annual operating income is $97.57 million, with the most recent change of +$10.25 million (+11.74%) on December 31, 2024.
- During the last 3 years, PCRX annual operating profit has fallen by -$35.26 million (-26.54%).
- PCRX annual operating profit is now -26.54% below its all-time high of $132.84 million, reached on December 31, 2021.
Performance
PCRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
$9.13M+$956.00K(+11.69%)Summary
- As of today, PCRX quarterly operating income is $9.13 million, with the most recent change of +$956.00 thousand (+11.69%) on June 30, 2025.
- Over the past year, PCRX quarterly operating profit has dropped by -$21.84 million (-70.51%).
- PCRX quarterly operating profit is now -79.64% below its all-time high of $44.87 million, reached on December 31, 2021.
Performance
PCRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$68.79M-$21.84M(-24.10%)Summary
- As of today, PCRX TTM operating income is $68.79 million, with the most recent change of -$21.84 million (-24.10%) on June 30, 2025.
- Over the past year, PCRX TTM operating profit has dropped by -$32.34 million (-31.98%).
- PCRX TTM operating profit is now -48.37% below its all-time high of $133.25 million, reached on March 31, 2022.
Performance
PCRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PCRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.7% | -70.5% | -32.0% |
| 3Y3 Years | -26.5% | -30.7% | -38.3% |
| 5Y5 Years | +173.2% | +259.4% | +69.3% |
PCRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -26.5% | +37.6% | -73.1% | +11.7% | -32.6% | +18.2% |
| 5Y | 5-Year | -26.5% | +173.2% | -79.6% | +11.7% | -48.4% | +69.3% |
| All-Time | All-Time | -26.5% | +283.1% | -79.6% | +143.8% | -48.4% | +210.6% |
PCRX Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $9.13M(+11.7%) | $68.79M(-24.1%) |
| Mar 2025 | - | $8.18M(-72.3%) | $90.64M(-7.1%) |
| Dec 2024 | $97.57M(+11.7%) | $29.53M(+34.6%) | $97.57M(-4.3%) |
| Sep 2024 | - | $21.95M(-29.1%) | $102.01M(+0.9%) |
| Jun 2024 | - | $30.98M(+104.9%) | $101.13M(+8.3%) |
| Mar 2024 | - | $15.12M(-55.5%) | $93.42M(+7.0%) |
| Dec 2023 | $87.32M(+23.1%) | $33.97M(+61.2%) | $87.32M(+29.2%) |
| Sep 2023 | - | $21.08M(-9.4%) | $67.60M(-1.0%) |
| Jun 2023 | - | $23.26M(+158.0%) | $68.30M(+17.3%) |
| Mar 2023 | - | $9.02M(-36.7%) | $58.21M(-17.9%) |
| Dec 2022 | $70.93M(-46.6%) | $14.24M(-34.6%) | $70.93M(-30.2%) |
| Sep 2022 | - | $21.78M(+65.3%) | $101.55M(-8.9%) |
| Jun 2022 | - | $13.18M(-39.4%) | $111.44M(-16.4%) |
| Mar 2022 | - | $21.73M(-51.6%) | $133.25M(+0.3%) |
| Dec 2021 | $132.84M(+157.9%) | $44.87M(+41.7%) | $132.84M(+17.0%) |
| Sep 2021 | - | $31.67M(-9.5%) | $113.52M(+13.3%) |
| Jun 2021 | - | $34.99M(+64.2%) | $100.16M(+68.5%) |
| Mar 2021 | - | $21.31M(-16.6%) | $59.44M(+15.4%) |
| Dec 2020 | $51.52M(+44.3%) | $25.55M(+39.5%) | $51.52M(+26.7%) |
| Sep 2020 | - | $18.31M(+419.6%) | $40.65M(+25.6%) |
| Jun 2020 | - | -$5.73M(-142.8%) | $32.37M(-30.8%) |
| Mar 2020 | - | $13.39M(-8.8%) | $46.77M(+31.0%) |
| Dec 2019 | $35.71M(+45.3%) | $14.68M(+46.3%) | $35.71M(+7.1%) |
| Sep 2019 | - | $10.03M(+15.6%) | $33.35M(+16.5%) |
| Jun 2019 | - | $8.68M(+274.0%) | $28.62M(+7.4%) |
| Mar 2019 | - | $2.32M(-81.2%) | $26.65M(+52.5%) |
| Dec 2018 | $24.58M(+289.5%) | $12.31M(+132.1%) | $17.48M(+27.2%) |
| Sep 2018 | - | $5.31M(-20.8%) | $13.74M(+168.3%) |
| Jun 2018 | - | $6.70M(+197.9%) | $5.12M(+139.8%) |
| Mar 2018 | - | -$6.85M(-179.8%) | -$12.87M(+35.9%) |
| Dec 2017 | -$12.97M | $8.58M(+359.0%) | -$20.07M(+35.5%) |
| Sep 2017 | - | -$3.31M(+70.7%) | -$31.11M(+36.1%) |
| Jun 2017 | - | -$11.29M(+19.7%) | -$48.66M(-11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$14.05M(-470.9%) | -$43.82M(-36.8%) |
| Dec 2016 | -$24.92M(-363.6%) | -$2.46M(+88.2%) | -$32.02M(-5.4%) |
| Sep 2016 | - | -$20.86M(-223.8%) | -$30.38M(-590.0%) |
| Jun 2016 | - | -$6.44M(-185.9%) | -$4.40M(-214.0%) |
| Mar 2016 | - | -$2.25M(-177.2%) | $3.86M(-59.2%) |
| Dec 2015 | $9.46M(+283.1%) | -$813.00K(-115.9%) | $9.46M(-48.0%) |
| Sep 2015 | - | $5.11M(+181.0%) | $18.19M(+50.4%) |
| Jun 2015 | - | $1.82M(-45.6%) | $12.09M(+62.7%) |
| Mar 2015 | - | $3.34M(-57.8%) | $7.43M(+243.8%) |
| Dec 2014 | -$5.17M(+90.3%) | $7.92M(+903.9%) | -$5.17M(+77.4%) |
| Sep 2014 | - | -$985.00K(+65.3%) | -$22.90M(+34.1%) |
| Jun 2014 | - | -$2.84M(+69.3%) | -$34.73M(+20.9%) |
| Mar 2014 | - | -$9.26M(+5.7%) | -$43.90M(+17.6%) |
| Dec 2013 | -$53.29M(-8.1%) | -$9.82M(+23.4%) | -$53.29M(+10.1%) |
| Sep 2013 | - | -$12.81M(-6.7%) | -$59.30M(+4.7%) |
| Jun 2013 | - | -$12.01M(+35.6%) | -$62.19M(-9.5%) |
| Mar 2013 | - | -$18.64M(-17.8%) | -$56.81M(-15.2%) |
| Dec 2012 | -$49.30M(-36.6%) | -$15.83M(-0.8%) | -$49.30M(-9.1%) |
| Sep 2012 | - | -$15.71M(-137.0%) | -$45.17M(-18.3%) |
| Jun 2012 | - | -$6.63M(+40.5%) | -$38.19M(+4.8%) |
| Mar 2012 | - | -$11.14M(+4.8%) | -$40.10M(-11.1%) |
| Dec 2011 | -$36.08M(-61.3%) | -$11.70M(-34.0%) | -$36.08M(-18.7%) |
| Sep 2011 | - | -$8.73M(-2.4%) | -$30.40M(-8.1%) |
| Jun 2011 | - | -$8.53M(-19.8%) | -$28.11M(-11.5%) |
| Mar 2011 | - | -$7.12M(-18.5%) | -$25.21M(-11.0%) |
| Dec 2010 | -$22.37M(+21.6%) | -$6.01M(+6.8%) | -$22.70M(+7.3%) |
| Sep 2010 | - | -$6.45M(-14.6%) | -$24.50M(-1.4%) |
| Jun 2010 | - | -$5.63M(-22.0%) | -$24.17M(-30.3%) |
| Mar 2010 | - | -$4.62M(+40.9%) | -$18.55M(-33.1%) |
| Dec 2009 | -$28.55M(+37.1%) | -$7.81M(-27.6%) | -$13.93M(-127.6%) |
| Sep 2009 | - | -$6.12M | -$6.12M |
| Dec 2008 | -$45.36M(-74.6%) | - | - |
| Dec 2007 | -$25.99M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual operating income?
- What is the all-time high annual operating profit for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual operating profit year-on-year change?
- What is Pacira BioSciences, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly operating profit year-on-year change?
- What is Pacira BioSciences, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM operating profit year-on-year change?
What is Pacira BioSciences, Inc. annual operating income?
The current annual operating profit of PCRX is $97.57M
What is the all-time high annual operating profit for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual operating income is $132.84M
What is Pacira BioSciences, Inc. annual operating profit year-on-year change?
Over the past year, PCRX annual operating income has changed by +$10.25M (+11.74%)
What is Pacira BioSciences, Inc. quarterly operating income?
The current quarterly operating profit of PCRX is $9.13M
What is the all-time high quarterly operating profit for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly operating income is $44.87M
What is Pacira BioSciences, Inc. quarterly operating profit year-on-year change?
Over the past year, PCRX quarterly operating income has changed by -$21.84M (-70.51%)
What is Pacira BioSciences, Inc. TTM operating income?
The current TTM operating profit of PCRX is $68.79M
What is the all-time high TTM operating profit for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM operating income is $133.25M
What is Pacira BioSciences, Inc. TTM operating profit year-on-year change?
Over the past year, PCRX TTM operating income has changed by -$32.34M (-31.98%)